17 results
PRE 14A
ALGS
Aligos Therapeutics, Inc.
16 Apr 24
Preliminary proxy
5:27pm
of the SEC and Nasdaq. Our Board has determined that Mr. Scopa is an audit committee financial expert as defined under the applicable rules of the SEC and has
8-K/A
59pg71z
24 Jun 21
Departure of Directors or Certain Officers
5:03pm
DEF 14A
lsleh02p7ifl2kxj3p
27 Apr 21
Definitive proxy
4:15pm
424B4
od2ntu
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1
btd58l35nlc3extjis5
25 Sep 20
IPO registration
5:27pm
S-1
EX-10.3
a882ok5n7lfyouh
25 Sep 20
IPO registration
5:27pm
DRS
3kso6c49izzn0f0 qg
26 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next